Business Standard

P&G Health Q3 results: PAT dips 21% to Rs 46 cr, revenue at Rs 252 cr

The company, which follows the July-June financial year, reported a profit after tax (PAT) of Rs 59 core a year ago

p&g, Procter & Gamble, tide

Its revenue from operations declined to Rs 252 crore for the period under review compared to Rs 321 crore in the year-ago period, Procter & Gamble (P&G) Health said in a regulatory filing.

Press Trust of India New Delhi

Listen to This Article

Procter & Gamble Health on Thursday said its profit after tax declined 21 per cent year-on-year to Rs 46 crore for the third quarter ended March 2024.
The company, which follows the July-June financial year, reported a profit after tax (PAT) of Rs 59 core a year ago.
Its revenue from operations declined to Rs 252 crore for the period under review compared to Rs 321 crore in the year-ago period, Procter & Gamble (P&G) Health said in a regulatory filing.
"The company's continued efforts to strengthen our reach and distribution with a transformed go-to-market model reflected in a one-time impact on the quarter's sales owing to the transition and optimisation of trade management and inventory," P&G Health India Managing Director Milind Thatte said.
"However, we have seen sales recover in the months of March and April," he added.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 02 2024 | 11:38 PM IST

Explore News